$CC

Chemours Announces Dates for Third Quarter 2026 Earnings Release and Webcast Conference Call

Chemours (NYSE: CC) will release Q3 2026 earnings after market close on Nov. 2, 2026, followed by a conference call on Nov. 3, 2026. The webcast and materials will be available on the company's investor relations website. Chemours is a global chemical company with products in various industries, headquartered in Wilmington, Delaware.

Original reporting
Published Oct 21, 2026, 8:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 21, 2026, 8:35 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Chemours Announces Dates for Third Quarter 2026 Earnings Release and Webcast Conference Call — source image
Decision brief

The 30-second read

$CCNeutralLow
01

Why it matters

The press release provides the schedule for the Q3 2026 earnings, which is new information for the market but does not contain financial metrics.

02

Market read

The announcement is primarily informational; it sets the timeline for the next earnings release with no immediate price impact.

03

What to watch

Potential hidden guidance or surprise in the upcoming earnings could change sentiment.

Relevance 4/10Novelty 5/10Timing: release scheduled for November 2‑3, 2026

Background

Chemours is a specialty chemicals producer listed on the NYSE under ticker CC. The company regularly announces earnings dates via press releases.

Company-level read

Ticker impact

$CCNeutralHigh confidence
Context

Chemours announced the dates for its Q3 2026 earnings release and webcast.

Expected impact

likely limited movement as investors await the actual results

Evidence & confidence

Without earnings numbers or guidance, the market typically shows little reaction to a release schedule.

Market effects

None significant; the announcement does not affect the broader chemicals sector.

Limited to investors tracking Chemours; no regional effect.

Minimal; only relevant to Chemours shareholders.

Counterpoint

Some traders may short ahead of the release expecting a miss, but no data supports a directional bet.

Key entities

  • Chemours Company

    Specialty chemicals manufacturer (NYSE: CC).

Related articles

$CCHigh

Why is Chemours stock sliding today?

Chemours (CC) stock fell 2.3% in pre-market trading after Mizuho downgraded it to Neutral and cut its price target to $15. RBC also downgraded it to Sector Perform, reducing its target to $14. Both analysts cited concerns over slower earnings growth and weak demand in key markets. The stock has lost over 40% in six months, trading near its 52-week low.

$CCMed

Mizuho downgrades Chemours stock rating on refrigerants delay

Mizuho downgraded Chemours (NYSE:CC) to Neutral from Outperform, lowering its price target to $15 from $18. The downgrade reflects slower-than-expected earnings growth from new refrigerants and concerns about titanium dioxide pigment market stability. Chemours' stock is down over 41% in the past six months, trading at $13.20. The company reported mixed Q2 2026 results, missing earnings and revenue estimates, and settled PFAS-related claims with North Carolina.

$CCHigh

Chemours falls as RBC downgrades stock on persistent TiO2 weakness

Chemours Co (CC) shares dropped 2.5% premarket after RBC downgraded it to Sector Perform, citing weak TiO2 demand and reduced growth expectations. RBC cut its price target to $14 from $22 and lowered EBITDA estimates for Q3 and FY26-FY27, citing macro pressures and project delays. The analyst sees limited near-term upside and a fully valued stock at current levels.

$CCMedAI 8/10

Corporations Are Dodging Accountability for PFAS Contamination Around the Globe

Chemours, a chemical company, has been linked to PFAS contamination in the Cape Fear River, North Carolina, affecting drinking water and health. The state reached a $590M settlement with Chemours for damages. PFAS contamination has also been reported near Chemours' facilities worldwide, raising concerns about global environmental and health impacts. Chemours inherited cleanup liabilities from its former parent company, DuPont, after a 2015 spin-off.